Ustekinumab trough levels in children with Crohn's disease refractory to anti-tumor necrosis factor agents: a prospective case series of off-label use.

Bouhuys, Marleen; Mian, Paola; van Rheenen, Patrick F

Bouhuys, Marleen; Mian, Paola; van Rheenen, Patrick F.

Afiliação

Bouhuys M; Department of Pediatric Gastroenterology, Hepatology and Nutrition, Beatrix Children's Hospital, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
Mian P; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, Netherlands.
van Rheenen PF; Department of Pediatric Gastroenterology, Hepatology and Nutrition, Beatrix Children's Hospital, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.

Front Pharmacol ; 14: 1180750, 2023.

Article em En | MEDLINE | ID: mdl-37818191

Palavras-chave

Crohn's disease; inflammatory bowel disease; pediatrics; therapeutic drug monitoring; ustekinumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google